Literature DB >> 9453607

Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis.

C Aebi1, L D Cope, J L Latimer, S E Thomas, C A Slaughter, G H McCracken, E J Hansen.   

Abstract

A monoclonal antibody (MAb) (MAb 10F3) directed against the CopB outer membrane protein of Moraxella catarrhalis previously was found to enhance pulmonary clearance of M. catarrhalis in an animal model (M. Helminen, I. Maciver, J. L. Latimer, L. D. Cope, G. H. McCracken, Jr., and E. J. Hansen, Infect. Immun. 61:2003-2010, 1993). In the present study, this same MAb was shown to exert complement-dependent bactericidal activity against this pathogen in vitro. Nucleotide sequence analysis of the copB gene from two MAb 10F3-reactive and two MAb 10F3-unreactive strains of M. catarrhalis revealed that the deduced amino acid sequences of these four CopB proteins were at least 90% identical. Comparison of the amino acid sequences of these proteins allowed localization of possible MAb 10F3 binding sites to five relatively small regions of the CopB protein from M. catarrhalis O35E. When five synthetic peptides representing these regions were tested for their ability to bind MAb 10F3 in a direct enzyme-linked immunosorbent assay system, an oligopeptide containing 26 amino acids was shown to bind this MAb. The actual binding region for MAb 10F3 was localized further through the use of overlapping decapeptides that spanned this 26-mer. A fusion protein containing the same 26-mer readily bound MAb 10F3 and was used to immunize mice. The resultant antiserum contained antibodies that reacted with the CopB protein of the homologous M. catarrhalis strain in Western blot analysis and bound to the surface of both homologous and heterologous strains of M. catarrhalis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453607      PMCID: PMC107939     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Mapping of a strain-specific bactericidal epitope to the surface-exposed loop 5 on the P2 porin protein of non-typeable Haemophilus influenzae.

Authors:  K Yi; T F Murphy
Journal:  Microb Pathog       Date:  1994-10       Impact factor: 3.738

2.  Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae.

Authors:  B Duim; L Vogel; W Puijk; H M Jansen; R H Meloen; J Dankert; L van Alphen
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Molecular characterization of FrpB, the 70-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis.

Authors:  A Pettersson; A Maas; D van Wassenaar; P van der Ley; J Tommassen
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

4.  Heterogeneity and structure of antibody-combining sites.

Authors:  E A Kabat
Journal:  Ann N Y Acad Sci       Date:  1970-02-13       Impact factor: 5.691

5.  Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin.

Authors:  C Aebi; B Stone; M Beucher; L D Cope; I Maciver; S E Thomas; G H McCracken; P F Sparling; E J Hansen
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.

Authors:  D Chen; J C McMichael; K R VanDerMeid; D Hahn; T Mininni; J Cowell; J Eldridge
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies.

Authors:  Y P Yang; L E Myers; U McGuinness; P Chong; Y Kwok; M H Klein; R E Harkness
Journal:  FEMS Immunol Med Microbiol       Date:  1997-03

8.  Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract.

Authors:  C B Hsiao; S Sethi; T F Murphy
Journal:  Microb Pathog       Date:  1995-10       Impact factor: 3.738

9.  Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

Authors:  M E Helminen; R Beach; I Maciver; G Jarosik; E J Hansen; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

10.  Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media.

Authors:  V N Gan; H Kusmiesz; S Shelton; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

View more
  19 in total

1.  Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.

Authors:  T F Murphy; C Kirkham; E DeNardin; S Sethi
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR.

Authors:  Oliver Greiner; Philip J R Day; Martin Altwegg; David Nadal
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

Review 3.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein.

Authors:  Ahmed S Attia; Eric J Hansen
Journal:  J Bacteriol       Date:  2006-09-08       Impact factor: 3.490

5.  Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.

Authors:  Shengqing Yu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Authors:  Ahmed S Attia; Eric R Lafontaine; Jo L Latimer; Christoph Aebi; George A Syrogiannopoulos; Eric J Hansen
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro.

Authors:  E R Lafontaine; L D Cope; C Aebi; J L Latimer; G H McCracken; E J Hansen
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

8.  Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function.

Authors:  Michael J Brooks; Jennifer L Sedillo; Nikki Wagner; Cassie A Laurence; Wei Wang; Ahmed S Attia; Eric J Hansen; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

Review 9.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

10.  Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.

Authors:  Ahmed S Attia; Sanjay Ram; Peter A Rice; Eric J Hansen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.